Blair William & CO Abb Vie Inc. Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Blair William & CO holds 1,166,215 shares of ABBV stock, worth $230 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

1,166,215

Previous 1,137,942 2.48%

Holding current value

$230 Million

Previous $207 Million 3.47%

% of portfolio

0.63%

Previous 0.66%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $4.38 Million - $5.11 Million	28,273 Added 2.48%	1,166,215 $200 Million
Q1 2024 May 09, 2024	BUY	$159.82 - $182.1 $13 Million - $14.8 Million	81,141 Added 7.68%	1,137,942 $207 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $1.81 Million - $2.04 Million	-13,140 Reduced 1.23%	1,056,801 $164 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $1.68 Million - $1.95 Million	-12,596 Reduced 1.16%	1,069,941 $159 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $9.69 Million - $12.1 Million	-73,092 Reduced 6.32%	1,082,537 $146 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $1.66 Million - $1.91 Million	-11,456 Reduced 0.98%	1,155,629 $184 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $4.33 Million - $5.19 Million	-31,282 Reduced 2.61%	1,167,085 $189 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $1.62 Million - $1.86 Million	12,066 Added 1.02%	1,198,367 $161 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $1.51 Million - $1.92 Million	-10,982 Reduced 0.92%	1,186,301 $182 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $44,345 - $55,020	-336 Reduced 0.03%	1,197,283 $194 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $8.96 Million - $11.3 Million	83,386 Added 7.48%	1,197,619 $162 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $8.52 Million - $9.67 Million	-80,055 Reduced 6.7%	1,114,233 $120 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $2.52 Million - $2.81 Million	-23,935 Reduced 1.96%	1,194,288 $135 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $1.1 Million - $1.21 Million	10,726 Added 0.89%	1,218,223 $132 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $5.88 Million - $7.94 Million	73,096 Added 6.44%	1,207,497 $129 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $9.52 Million - $11.2 Million	110,846 Added 10.83%	1,134,401 $99.4 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $6.93 Million - $9.28 Million	94,490 Added 10.17%	1,023,555 $100 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $2.18 Million - $3.31 Million	33,851 Added 3.78%	929,065 $70.8 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $5 Million - $6.26 Million	69,365 Added 8.4%	895,214 $79.3 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $2.09 Million - $2.51 Million	33,158 Added 4.18%	825,849 $62.5 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $932,545 - $1.19 Million	14,194 Added 1.82%	792,691 $57.6 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $1.83 Million - $2.16 Million	-23,757 Reduced 2.96%	778,497 $62.7 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $28,415 - $35,043	-365 Reduced 0.05%	802,254 $74 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $1.62 Million - $1.8 Million	18,223 Added 2.32%	802,619 $75.9 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $1.37 Million - $1.62 Million	-15,217 Reduced 1.9%	784,396 $72.7 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $2.12 Million - $2.83 Million	-23,002 Reduced 2.8%	799,613 $75.7 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $731,078 - $801,688	8,163 Added 1.0%	822,615 $79.6 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $56.9 Million - $72.7 Million	814,452	814,452 $72.4 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account